Paralos Bioscience Inc.
Paralos Bioscience Inc. is developing phage-drug conjugates using a modular M13 phage drug delivery platform designed to concentrate payloads at specific targets.
Funding history
About Paralos Bioscience Inc.
How much funding has Paralos Bioscience Inc. raised?
Paralos Bioscience Inc. has raised $1.2M in total funding. The most recent round was Seed.
Where is Paralos Bioscience Inc. headquartered?
Paralos Bioscience Inc. is headquartered in Los Angeles, CA.
What does Paralos Bioscience Inc. do?
Paralos Bioscience Inc. is developing phage-drug conjugates using a modular M13 phage drug delivery platform designed to concentrate payloads at specific targets.
What makes Paralos Bioscience Inc. notable?
Paralos Bioscience, co-founded by Yanxi Yang, is developing a phage-drug conjugate platform targeting drug-resistant infections and has been backed by Carbon Silicon Ventures, Larta Institute, Incate, and UCLA's Magnify program.
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
